Page last updated: 2024-08-25

3,4-dihydroxyphenylethanol and Infections, Coronavirus

3,4-dihydroxyphenylethanol has been researched along with Infections, Coronavirus in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Beccari, T; Bertelli, M; Capodicasa, N; Ceccarini, MR; Codini, M; Dundar, M; Ergoren, MC; Farronato, G; Farronato, M; Kroni, D; Manara, E; Paolacci, S; Percio, M; Sanlidag, T; Tartaglia, GM; Tezzele, S1
Anpilogov, K; Bertelli, M; Camilleri, G; Dautaj, A; Dhuli, K; Dundar, M; Ergoren, MC; Farronato, G; Farronato, M; Gunsel, IS; Manara, E; Paolacci, S; Sanlidag, T; Sayan, M; Suer, HK; Sultanoglu, N; Tartaglia, GM; Tuncel, G1

Other Studies

2 other study(ies) available for 3,4-dihydroxyphenylethanol and Infections, Coronavirus

ArticleYear
Pilot study for the evaluation of safety profile of a potential inhibitor of SARS-CoV-2 endocytosis.
    Acta bio-medica : Atenei Parmensis, 2020, 11-09, Volume: 91, Issue:13-S

    Topics: Adult; Aged; Aged, 80 and over; alpha-Cyclodextrins; Antiviral Agents; Betacoronavirus; Caco-2 Cells; Cell Culture Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Endocytosis; Female; Humans; Male; Middle Aged; Oral Sprays; Pandemics; Phenylethyl Alcohol; Pilot Projects; Pneumonia, Viral; SARS-CoV-2; Young Adult

2020
A pilot study on the preventative potential of alpha-cyclodextrin and hydroxytyrosol against SARS-CoV-2 transmission.
    Acta bio-medica : Atenei Parmensis, 2020, 11-09, Volume: 91, Issue:13-S

    Topics: Adult; alpha-Cyclodextrins; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cyprus; Endocytosis; Female; Humans; Male; Middle Aged; Oral Sprays; Pandemics; Phenylethyl Alcohol; Pilot Projects; Pneumonia, Viral; SARS-CoV-2; Viral Load

2020